valrubicin has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lacko, AG; Raut, S; Sabnis, NA; Sabnis, S | 1 |
1 other study(ies) available for valrubicin and Prostatic Neoplasms
| Article | Year |
|---|---|
Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dextrans; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Humans; Iron; Lipoproteins, HDL; Magnetite Nanoparticles; Male; Prostatic Neoplasms; Scavenger Receptors, Class B | 2017 |